Philips Buys Respironics For $5.1 Bil. To Build Home Health Care Business
This article was originally published in The Gray Sheet
Executive Summary
Philips will add obstructive sleep apnea and respiratory care products to its burgeoning home health care franchise through the $5.1 billion acquisition of Respironics, announced Dec. 21